β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretion

Objective‍ ‍To investigate the protective effect of β-glucan (BG) against intestinal ischemia reperfusion (II/R) injury by regulating the secretion of glucagon-like peptide-1 (GLP-1). Methods‍ ‍Male C57BL/6 mice (6~8 weeks old) were subjected, and finally, the experiments had sham group, II/R group,...

Full description

Saved in:
Bibliographic Details
Main Authors: WANG Wei, HAN Ben, SUN Lihua
Format: Article
Language:zho
Published: Editorial Office of Journal of Army Medical University 2025-01-01
Series:陆军军医大学学报
Subjects:
Online Access:https://aammt.tmmu.edu.cn/html/202409020.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590823367114752
author WANG Wei
HAN Ben
SUN Lihua
author_facet WANG Wei
HAN Ben
SUN Lihua
author_sort WANG Wei
collection DOAJ
description Objective‍ ‍To investigate the protective effect of β-glucan (BG) against intestinal ischemia reperfusion (II/R) injury by regulating the secretion of glucagon-like peptide-1 (GLP-1). Methods‍ ‍Male C57BL/6 mice (6~8 weeks old) were subjected, and finally, the experiments had sham group, II/R group, II/R+BG group (0.1 mg/mL BG in drinking water for 2 weeks before modeling), II/R+liraglutide (LLT, GLP-1 analogue) group (0.2 μg/g LLT injected every 12 hours for 3 consecutive days before modeling), and II/R+BG+Ex9-39 (GLP-1R antagonist) group (intraperitoneal injection of 2 μg/g Ex9-39 1 h before modeling). After modeling, HE staining was used to observe intestinal morphological changes, and RT-qPCR and Western blotting were employed to evaluate the molecules (Occludin, ZO-1 and Claudin-1) related to intestinal barrier damage. The effect of 0.1 mg/mL BG treatment on the GLP-1 level in the serum and intestinal tissues of normal mice was determined with ELISA and immunofluorescence assay, respectively, and RT-PCR for the molecules related to GLP-1 expression (Gcg, Pcsk1/2, GIP and Foxa2). The effects of LLT and Ex9-39 pretreatment on intestinal morphology and intestinal barrier damage were also determined by morphological observation and expression levels of related molecules. Results‍ ‍II/R induced significant decreases in the mRNA levels of Occludin, ZO-1 and Claudin-1 and increase in Chiu's score when compared with sham control mice (P<0.05). While, the mRNA levels of the 3 molecules were obviously higher and the Chiu's score was lower in the II/R+BG group than the II/R group (P<0.05). BG pretreatment induced notably enhanced secretion of GLP-1 in the serum and intestinal tract of normal mice, and improved the mRNA expression of GLP-1-related molecules (P<0.05). The intervention of GLP-1 analogue LLT could attenuate the II/R damage and decreased Chiu's score, with statistical difference in comparison with the II/R group (P<0.05). GLP-1 receptor antagonist Ex9-39 reversed the protective effects of BG pretreatment against II/R damage, with notably differences in the expression of Occludin, ZO-1 and Claudin-1 and Chiu's score (P<0.05). Conclusion‍ ‍BG can attenuate intestinal mucosal and functional injury after II/R by promoting intestinal GLP-1 secretion.
format Article
id doaj-art-7c33808a8ebf4414ba40919948640f06
institution Kabale University
issn 2097-0927
language zho
publishDate 2025-01-01
publisher Editorial Office of Journal of Army Medical University
record_format Article
series 陆军军医大学学报
spelling doaj-art-7c33808a8ebf4414ba40919948640f062025-01-23T07:52:22ZzhoEditorial Office of Journal of Army Medical University陆军军医大学学报2097-09272025-01-0147211212110.16016/j.2097-0927.202409020β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretionWANG Wei0HAN Ben1SUN Lihua2Department of Nutrition, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, ChinaDepartment of Nutrition, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, ChinaDepartment of General Surgery, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, ChinaObjective‍ ‍To investigate the protective effect of β-glucan (BG) against intestinal ischemia reperfusion (II/R) injury by regulating the secretion of glucagon-like peptide-1 (GLP-1). Methods‍ ‍Male C57BL/6 mice (6~8 weeks old) were subjected, and finally, the experiments had sham group, II/R group, II/R+BG group (0.1 mg/mL BG in drinking water for 2 weeks before modeling), II/R+liraglutide (LLT, GLP-1 analogue) group (0.2 μg/g LLT injected every 12 hours for 3 consecutive days before modeling), and II/R+BG+Ex9-39 (GLP-1R antagonist) group (intraperitoneal injection of 2 μg/g Ex9-39 1 h before modeling). After modeling, HE staining was used to observe intestinal morphological changes, and RT-qPCR and Western blotting were employed to evaluate the molecules (Occludin, ZO-1 and Claudin-1) related to intestinal barrier damage. The effect of 0.1 mg/mL BG treatment on the GLP-1 level in the serum and intestinal tissues of normal mice was determined with ELISA and immunofluorescence assay, respectively, and RT-PCR for the molecules related to GLP-1 expression (Gcg, Pcsk1/2, GIP and Foxa2). The effects of LLT and Ex9-39 pretreatment on intestinal morphology and intestinal barrier damage were also determined by morphological observation and expression levels of related molecules. Results‍ ‍II/R induced significant decreases in the mRNA levels of Occludin, ZO-1 and Claudin-1 and increase in Chiu's score when compared with sham control mice (P<0.05). While, the mRNA levels of the 3 molecules were obviously higher and the Chiu's score was lower in the II/R+BG group than the II/R group (P<0.05). BG pretreatment induced notably enhanced secretion of GLP-1 in the serum and intestinal tract of normal mice, and improved the mRNA expression of GLP-1-related molecules (P<0.05). The intervention of GLP-1 analogue LLT could attenuate the II/R damage and decreased Chiu's score, with statistical difference in comparison with the II/R group (P<0.05). GLP-1 receptor antagonist Ex9-39 reversed the protective effects of BG pretreatment against II/R damage, with notably differences in the expression of Occludin, ZO-1 and Claudin-1 and Chiu's score (P<0.05). Conclusion‍ ‍BG can attenuate intestinal mucosal and functional injury after II/R by promoting intestinal GLP-1 secretion. https://aammt.tmmu.edu.cn/html/202409020.html‍intestinal ischaemia-reperfusion injuryβ-glucanglucagon-like peptide-1intestinal barrier
spellingShingle WANG Wei
HAN Ben
SUN Lihua
β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretion
陆军军医大学学报
‍intestinal ischaemia-reperfusion injury
β-glucan
glucagon-like peptide-1
intestinal barrier
title β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretion
title_full β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretion
title_fullStr β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretion
title_full_unstemmed β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretion
title_short β-glucan attenuates intestinal ischemia-reperfusion injury in mice by promoting glucagon-like peptide-1 secretion
title_sort β glucan attenuates intestinal ischemia reperfusion injury in mice by promoting glucagon like peptide 1 secretion
topic ‍intestinal ischaemia-reperfusion injury
β-glucan
glucagon-like peptide-1
intestinal barrier
url https://aammt.tmmu.edu.cn/html/202409020.html
work_keys_str_mv AT wangwei bglucanattenuatesintestinalischemiareperfusioninjuryinmicebypromotingglucagonlikepeptide1secretion
AT hanben bglucanattenuatesintestinalischemiareperfusioninjuryinmicebypromotingglucagonlikepeptide1secretion
AT sunlihua bglucanattenuatesintestinalischemiareperfusioninjuryinmicebypromotingglucagonlikepeptide1secretion